124980-97-8Relevant articles and documents
Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors
Webber, Stephen E.,Marakovits, Joseph T.,Dragovich, Peter S.,Prins, Thomas J.,Zhou, Ru,Fuhrman, Shella A.,Patick, Amy K.,Matthews, David A.,Lee, Caroline A.,Srinivasan, Babu,Moran, Terry,Ford, Clifford E.,Brothers, Mary A.,Harr, James E.V.,Meador III, James W.,Ferre, Rose Ann,Worland, Stephen T.
, p. 2683 - 2686 (2007/10/03)
Novel tripeptidyl C-terminal Michael acceptors with an ester replacement of the P2-P3 amide bond were investigated as irreversible inhibitors of the human rhinovirus (HRV) 3C protease (3CP). When screened against HRV serotype-14 the best compound was shown to have very good 3CP inhibition (kobs/[I]=270,000 M-1 s-1) and potent in vitro antiviral activity (EC50=7.0 nM).